Quantcast
Last updated on April 17, 2014 at 14:25 EDT

Latest Acute exacerbation of chronic obstructive pulmonary disease Stories

2014-03-30 23:04:28

Respiratory Therapists (RTs) represent the single best resource to help improve the health outcomes, quality of life, and reduce the costs associated with the treatment and management of patients who are diagnosed with chronic obstructive pulmonary disease (COPD). The clinical trial will validate the effectiveness of RTs in improving health and financial outcomes. San Diego, CA (PRWEB) March 30, 2014 The Centers for Medicare and Medicaid Services (CMS) will include patients admitted for...

2014-03-03 23:27:59

The Use of Respiratory Therapists as case managers or physician extenders will improve health outcomes, reduce costs and help organizations to demonstrate meaningful use for patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). SAN DIEGO, CA (PRWEB) March 03, 2014 Respiratory Patient Centered Care is designed to meet the complex needs of patients that are diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Respiratory Therapists (RTs) are key to the success of...

2014-01-14 12:26:46

BETHESDA, Md., Jan. 14, 2014 /PRNewswire/ -- Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced that the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, has released its first draft qualification guidance document for a patient-reported outcome (PRO) measure in drug development: Qualification of Exacerbations of Chronic Pulmonary Disease Tool [EXACT] for Measurement of Symptoms of Acute Bacterial...

2013-12-11 08:32:30

GLENDALE, Calif. and RIDGEFIELD, Conn., Dec. 11, 2013 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), an integrated physician-driven healthcare delivery company, and Boehringer Ingelheim Pharmaceuticals, Inc., a research-based, global pharmaceutical company, today announced a partnership dedicated to managing the care of ApolloMed ACO patients with chronic obstructive pulmonary disease (COPD). Boehringer Ingelheim has a vast array of provider and patient...

Yoga Can Help Patients With COPD Improve Lung Function
2013-10-29 06:18:51

April Flowers for redOrbit.com - Your Universe Online A new study from researchers at the All India Institute of Medical Sciences, Department of Pulmonary Medicine and Sleep Disorders reveals that patients with COPD can improve their lung function by practicing yoga. The study found that lung function, shortness of breath and inflammation all demonstrated significant improvement after patients completed 12 weeks of yoga training. The study results were presented at CHEST 2013, the...

2013-09-08 20:20:21

Results presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 RIDGEFIELD, Conn., Sept. 8, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the results of TIOSPIR(TM) (Tiotropium Safety and Performance in Respimat) (NCT01126437), one of the largest international chronic obstructive pulmonary disease (COPD) trials conducted to date, at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, Spain. The...

2013-06-17 08:28:01

MISSISSAUGA, ON, June 17, 2013 /CNW/ - A second analysis of data from real-world study PATHOS, recently published in the British Medical Journal, shows that treatment of chronic obstructive pulmonary disease (COPD) patients with SYMBICORT(®) (budesonide/formoterol) was associated with a lower incidence of pneumonia and pneumonia related death, compared to treatment of COPD patients with ADVAIR(®) (fluticasone/salmeterol).(i) PATHOS is the largest real-world study to compare the...

2013-06-12 10:54:43

Simultaneously elevated levels of the biomarkers C-reactive protein, fibrinogen and leukocyte count in individuals with chronic obstructive pulmonary disease (COPD) were associated with increased risk of having exacerbations, even in those with milder COPD and in those without previous exacerbations, according to a study in the June 12 issue of JAMA. "Exacerbations of respiratory symptoms in COPD are of major importance because of their profound and long-lasting adverse effects on...

Almost Half Of COPD Diagnoses Are Wrong
2013-05-22 12:56:06

Peter Suciu for redOrbit.com — Your Universe Online A new study has found that chronic obstructive pulmonary disease (COPD) is over-diagnosed among uninsured patients. Researchers found that over 40 percent of patients being treated for COPD at federally funded clinics did not actually have the disease. COPD is a progressive lung disease that leads to the loss of lung function and is primarily caused by smoking. The disease causes coughing, wheezing, shortness of breath, chest...

2013-05-17 08:23:49

Data on investigational compounds and an approved product will be presented RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- Boehringer Ingelheim will contribute to advancing the scientific discussion in respiratory disease at the American Thoracic Society International Conference (ATS 2013) in Philadelphia, PA, May 17 - 22.( )Data will highlight research conducted with a product approved for the treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler®...